Lastimado, Generose M.

HRN: 11-89-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
12/06/2022
12/12/2022
IVT
200mg
OD
Cystic Fibrosis; CAP MR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: